Search the Newsreel

Replimune stock upgraded at Cantor on FDA vote (REPL:NASDAQ)

Replimune (REPL) shares rebounded following an upgrade by Cantor Fitzgerald. The upgrade came after an FDA advisory committee voted favorably for the company's lead drug, RP1, which targets melanoma. This positive development occurred despite a prior multi-day decline in the stock earlier in the …

Republic Services, Inc. $RSG Shares Bought by Royal Bank of Canada

Royal Bank of Canada increased its stake in Republic Services (NYSE:RSG) by 10.9% in the first quarter, now holding 708,878 shares valued at $155.3 million. Institutional investors collectively own 57.73% of the company, which maintains a "Moderate Buy" consensus rating and an average price …

SRPT|Sarepta Therapeutics Inc|Price:15.560|Chg%:+0.025

This article

AMREP Corp (AXR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for AMREP Corp (AXR), highlighting its current risk score of 3.48, ranking 32 out of 41 in the Construction & Engineering industry. It details the company's beta value of 1.14, indicating higher volatility compared to the S&P 500. …

REPL Stock Jumps As FDA Panel Backs Melanoma Drug

Replimune Group Inc. (REPL) stock jumped significantly after an FDA advisory panel voted 10-3 in favor of the efficacy data for its melanoma therapy, RP1 plus nivolumab, from the IGNYTE trial. This positive recommendation de-risks the company's ongoing Biologics License Application (BLA) resubmission ahead …

California State Teachers Retirement System Has $55.10 Million Stake in Republic Services, Inc. $RSG

The California State Teachers Retirement System recently reduced its stake in Republic Services, Inc. by 2.8%, selling 7,363 shares but still holding 251,568 shares valued at approximately $55.1 million. Institutional investors collectively own 57.73% of the company, which maintains a "Moderate Buy" consensus rating …

Travelers pursues Republic Services for $21 million over alleged recycling center fire

Travelers Insurance Company and the City of Milwaukee are suing Republic Services for nearly $21 million over a fire at a Milwaukee recycling center that occurred on May 31, 2023. The lawsuit, filed on July 30, 2026, alleges negligence and breach of contract, claiming …

RJET|Republic Airways Holdings Ord Shs|Price:20.330|Chg%:-0.250

REPL Q2 2026 Earnings: Clinical Momentum Overrides EPS Miss as Shares Soar 107% - Adjusted Earnings Analysis

Republic Airways (NASDAQ: RJET) grows revenue after Mesa merger

Republic Airways Holdings (RJET) Stock Drops As Mesa Integration Drives Outlook Shift

Republic Bancorp (NASDAQ:RBCAA) Sees Large Volume Increase - Should You Buy?

Telkom Indonesia (NYSE: TLK) earns Rp14,206B profit on Rp75,878B sales

Sarepta Therapeutics (SRPT) Could Be 28% Below Fair Value As New CEO Takes Over

Sarepta Therapeutics (SRPT) has appointed Michael Severino, M.D., as its new CEO, effective July 28, 2026. Despite a recent modest share price gain, the stock has seen significant declines year-to-date and over the past five years. Analysts suggest SRPT could be 28.3% undervalued with …

IRSA Inversiones y Representaciones SA (IRS): Análisis de PE, PB y Valor Razonable

This article provides an analysis of IRSA Inversiones y Representaciones SA (IRS), focusing on its valuation score. The company currently has a valuation score of 6.55, ranking 38th out of 46 in the Real Estate Operations industry. Its current P/E ratio is 2.92, which …

Republic Services Marks Nearly $1 Billion in Sustainability Investments in 2025

Republic Services announced nearly $1 billion in sustainability investments for 2025, with a focus on advanced recycling, renewable natural gas projects, and electrifying its vehicle fleet. These investments are projected to reduce annual emissions by 1.6 million metric tons and generate over $100 million …

Old Republic International Insider Sold Shares Worth $576,975, According to a Recent SEC Filing

An insider at Old Republic International recently sold shares valued at $576,975, as disclosed in a recent SEC filing. This transaction may be of interest to investors tracking insider activity and stock performance. Further details would typically include the insider's identity, the number of …

Replimune stock surges on positive AdCom vote (REPL:NASDAQ)

Replimune's stock more than doubled in post-market trading after the FDA's Cellular, Tissue, and Gene Therapies Advisory Committee voted favorably on the company's lead asset, RP1. This positive AdCom vote precedes a key target date of August 2. The significant surge indicates strong investor …

Amrep Corp (AXR) CFO and VP Adrienne Uleau Sells 4,000 Shares

Amrep Corp's CFO and VP, Adrienne Uleau, sold 4,000 shares of the company's stock for approximately $93,960. While this is the only insider sell over the past year, the company has seen 17 insider buys during the same period, suggesting a generally positive outlook …

OLD REPUBLIC INTERNATIONAL CORP SEC Filing (Jul 30, 2026)

This article details an SEC Form 144 filing by Old Republic International Corp (ORI) concerning a proposed sale of securities, specifically 14,075 shares of common stock valued at $615,308.85. The filing, accepted by the SEC on July 30, 2026, at 04:26 PM, lists Merrill …

Old Republic (NYSE: ORI) EVP exercises options and sells 13,125 shares

Stephen J. Oberst, Executive Vice President of Old Republic International (NYSE: ORI), exercised 208,000 employee stock options on July 28, 2026. Following the exercise, 150,068 shares were withheld for taxes and the exercise price, and he sold 13,125 shares at a weighted average price …

Understanding Momentum Shifts in (IRS)

This article analyzes Irsa Inversiones Y Representaciones S.a. (NYSE: IRS), identifying a mid-channel oscillation pattern and a strong risk-reward short setup. It details institutional trading strategies, including long, breakout, and short positions, based on AI-generated signals for various time horizons. The analysis highlights prevailing …

FDA Panel Votes In Favor of Replimune’s Melanoma Treatment

An FDA advisory panel voted 10-3 in favor of Replimune Group's experimental melanoma therapy, despite regulators' earlier concerns about the trial design and data. This recommendation follows a contentious meeting and a significant drop in Replimune's stock price after a critical FDA analysis. The …

Replimune Announces Favorable Outcome of FDA's Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

WOBURN, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the outcome of today's meeting of the U.S. Food and Drug Administration's (FDA) Cellular, Tissue, and Gene Therapies …

AMREP (NYSE:AXR) CFO Sells $93,960.00 in Stock

AMREP's CFO, Adrienne Uleau, sold 4,000 shares of company stock for a total of $93,960.00, reducing her direct holdings by 37.83%. This transaction follows the company's recent quarterly earnings which missed analyst expectations for both EPS and revenue. The stock traded below its 50-day …

Bragar Eagel & Squire, P.C. is Investigating Replimune

Bragar Eagel & Squire, P.C., a stockholder rights law firm, is investigating potential claims against Replimune Group Inc. following a significant stock drop. The investigation comes after the FDA deemed Replimune's single-arm mid-stage study for its drug RP1 for skin cancer as "not interpretable," …

Republic Services Number of Employees 2026 | Employee Count & Headcount Data

Republic Services, Inc. (RSG) had approximately 42,084 total employees worldwide as of March 2026, marking a 0.6% decline from 2025. The company is actively hiring with 2,886 job postings in 2026, though new postings per month have cooled. The majority of its workforce is …

IRSA (NYSE: IRS) inks $4M Ramblas del Plata barter deal

IRSA Inversiones y Representaciones S.A. (NYSE: IRS) has signed a $4 million barter agreement for a new 2,360 sqm lot within the extended first stage of its Ramblas del Plata real estate project. The lot has an estimated total saleable area of 4,500 sqm. …

Repligen (RGEN) Stock Faces A Margin Puzzle After Revenue Growth

Repligen (RGEN) recently reported Q2 2026 earnings with revenue growth and expanded adjusted gross and operating margins, despite a slip in net income. The article discusses the bull and bear cases for the stock, focusing on the company's shift towards recurring revenue and its …

Mesa Air Group Q2 Earnings Call Highlights

Key Points Interested in Mesa Air Group, Inc.? Here are five stocks we like better. Second-quarter performance improved: Republic Airways increased block-hour production 7% sequentially and revenue 8% to approximately $571 million. Adjusted net income was $41 million, or $0.89 per diluted share, while …

Republic Services Inc. stock outperforms competitors despite losses on the day

Shares of Republic Services Inc. (RSG) fell by 3.46% to $211.33 on Thursday, despite a strong day for the broader stock market with the S&P 500 Index and Dow Jones Industrial Average both rising. The company's stock closed 12.28% below its 52-week high reached …

3 Promising Penny Stocks With Market Caps Up To $200M

This article identifies three promising penny stocks with market caps up to $200 million: KORU Medical Systems (KRMD), Planet Image International (YIBO), and Zevia PBC (ZVIA). Despite a recent drop in the U.S. market, these companies exhibit potential for growth, robust financial health, and …

Replimune’s RP-1 for melanoma wins over FDA adcom

Replimune Group Inc.'s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma, refractory to PD-1 therapy, received a positive vote from the U.S. FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee. The committee voted 10-3 that the efficacy results from the Ignyte phase II study …

Replimune: 'Sell' Continued Doubt On Single-Arm IGNYTE Trial For RP1 FDA Review (REPL)

Replimune Group, Inc. has been downgraded to 'Sell' due to ongoing FDA concerns regarding its RP1 + OPDIVO combination for advanced melanoma. The FDA's briefing documents highlight issues with the reliance on the single-arm IGNYTE trial, lack of a control arm, and a questionable …

KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Consensus Rating of "Moderate Buy" by Brokerages

KORU Medical Systems (NASDAQ:KRMD) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $7.25. Insiders have recently purchased shares worth approximately $109,430, and the stock traded up 0.9% to $4.11. The company develops and manufactures medical devices …

Republic Services (RSG) Earnings Expected to Grow: Should You Buy?

Wall Street expects a year-over-year increase in earnings on higher revenues when Republic Services (RSG) reports results for the quarter ended June 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term …